RNAC

Cartesian Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel cell therapies for autoimmune diseases. The company utilizes its proprietary RNA chimeric antigen receptor (RNA CAR) technology to create off-the-shelf cellular immunotherapies. Cartesian is focused on B cell-mediated autoimmune conditions with significant unmet medical needs.